Soleno Therapeutics (SLNO) Other financing activities (2014 - 2025)

Soleno Therapeutics (SLNO) has 8 years of Other financing activities data on file, last reported at $679000.0 in Q4 2025.

• Other financing activities for Q4 2025 came in at $679000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $712000.0 (up 259.6% YoY), and the FY2025 annual result was $741000.0, changed N/A from the prior year.
• Other financing activities rose to $679000.0 in Q4 2025 per SLNO's latest filing, from $33000.0 in the prior quarter.
• Over five years, Other financing activities peaked at $679000.0 in Q4 2025 and troughed at $16000.0 in Q1 2022.
• A 3-year average of $182000.0 and a median of $62000.0 in 2025 frame the typical range for Other financing activities.
• On a YoY basis, Other financing activities climbed as much as 86.67% in 2022 and fell as far as 86.67% in 2022.
• A 3-year view of Other financing activities shows it stood at $120000.0 in 2021, then sank by 86.67% to $16000.0 in 2022, then soared by 4143.75% to $679000.0 in 2025.
• Business Quant data shows SLNO's Other financing activities at $679000.0 in Q4 2025, $33000.0 in Q2 2025, and $62000.0 in Q1 2025.